Nucleic acid testing (NAT) in high prevalence–low resource settings
- 31 January 2010
- journal article
- review article
- Published by Elsevier BV in Biologicals
- Vol. 38 (1), 59-64
- https://doi.org/10.1016/j.biologicals.2009.10.015
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South AfricaTransfusion, 2009
- Anti‐HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmissionTransfusion Medicine, 2008
- Use of replacement blood donors to study the epidemiology of major blood‐borne viruses in the general population of Maputo, MozambiqueJournal of Medical Virology, 2007
- Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern ThailandTransfusion, 2007
- Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and resultsRevista do Instituto de Medicina Tropical de São Paulo, 2007
- Replacement of HIV p24 Ag test by a multiplex RT-PCR method for primary screening of blood donorsRevista do Instituto de Medicina Tropical de São Paulo, 2007
- Hepatitis B virus DNA in blood donors with anti‐HBc as a possible indicator of active hepatitis B virus infection in Yucatan, MexicoTransfusion Medicine, 2005
- Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testingVox Sanguinis, 2005
- High prevalence of hepatitis B, C and delta virus infections among blood donors in MongoliaArchiv für die gesamte Virusforschung, 2005
- HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementationTransfusion, 2003